المؤلفون: Catharina G. Faber, W. Ludo van der Pol, Vera Bril, Kenneth C. Gorson, Peter Van den Bergh, Sonja I. van Nes, Mayienne Bakkers, Ingemar S. J. Merkies, Michael P. Lunn, Leonard H. van den Berg, Eduardo Nobile-Orazio, Hans D. Katzberg, Anneke J. van der Kooi, Nicolette C. Notermans, Richard A. Lewis, Els K. Vanhoutte, Angelika F. Hahn, Pieter A. van Doorn, Mariëlle H J Pruppers, Jean Marc Léger, Jean Pouget, David R. Cornblath, Thomas H P Draak, Giuseppe Lauria

المصدر: Journal of the Peripheral Nervous System. 20:269-276

مصطلحات موضوعية: medicine.medical_specialty, General Neuroscience, Minimal clinically important difference, Mismatch negativity, Polyradiculoneuropathy, medicine.disease, Grip strength, medicine, Comparison study, Physical therapy, In patient, Neurology (clinical), Psychology, Polyneuropathy, Multifocal motor neuropathy

الوصف: The Jamar dynamometer and Vigorimeter have been used to assess grip strength in immune-mediated neuropathies, but have never been compared to each other. Therefore, we performed a comparison study between these two devices in patients with immune-mediated neuropathies. Grip strength data were collected in 102 cross-sectional stable and 163 longitudinal (new diagnoses or changing condition) patients with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), gammopathy-related polyneuropathy (MGUSP), and multifocal motor neuropathy (MMN). Stable patients were assessed twice (validity/reliability studies). Longitudinal patients were assessed 3-5 times during 1 year. Responsiveness comparison between the two tools was examined using combined anchor-/distribution-based minimum clinically important difference (MCID) techniques. Patients were asked to indicate their preference for the Jamar or Vigorimeter. Both tools correlated highly with each other (ρ = 0.86, p < 0.0001) and showed good intra-class correlation coefficients (Jamar [Right/Left hands]: ICC 0.997/0.96; Vigori: ICC 0.95/0.98). Meaningful changes were comparable between the two instruments, being higher in GBS compared to CIDP patients. In MGUSP/MMN poor responsiveness was seen. Significant more patients preferred the Vigorimeter. In conclusion, validity, reliability, and responsiveness aspects were comparable between the Jamar dynamometer and Vigorimeter. However, based on patients' preference, the Vigorimeter is recommended in future studies in immune-mediated neuropathies.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c5c63f05a91a01f99be98de4e90023f3Test
https://doi.org/10.1111/jns.12126Test

المؤلفون: E. Morra, E. Evers, A. Hahn, Claudia Sommer, Richard A. C. Hughes, Carol L. Koski, Peter Van den Bergh, Jean Marc Léger, Eduardo Nobile-Orazio, John D. Pollard, Robert D M Hadden, Pierre Bouche, Pieter A. van Doorn, David R. Cornblath, Isabel Illa, Ivo N. van Schaik

المساهمون: AII - Amsterdam institute for Infection and Immunity, ANS - Amsterdam Neuroscience, Neurology

المصدر: Journal of the peripheral nervous system, 15(4), 295-301. Wiley-Blackwell
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: medicine.medical_specialty, diagnosis, multifocal motor neuropathy, Advisory Committees, MEDLINE, Mismatch negativity, Polyneuropathies, Physical medicine and rehabilitation, Peripheral nerve, definition, Humans, Medicine, guidelines, Peripheral Nerves, Societies, Medical, First revision, treatment, Task force, business.industry, General Neuroscience, Disease Management, Guideline, medicine.disease, Europe, Systematic review, Practice Guidelines as Topic, Physical therapy, Neurology (clinical), Nervous System Diseases, business, Multifocal motor neuropathy

الوصف: A European Federation of Neurological Societies/Peripheral Nerve Society consensus guideline on the definition, investigation, and treatment of multifocal motor neuropathy (MMN) was published in 2006. The aim is to revise this guideline. Disease experts considered references retrieved from MEDLINE and Cochrane Systematic Reviews published between August 2004 and July 2009 and prepared statements that were agreed to in an iterative fashion. The Task Force agreed on Good Practice Points to define clinical and electrophysiological diagnostic criteria for MMN, investigations to be considered, and principal recommendations for treatment.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d09fd115e568aec033fbe9966f82bf4Test
https://doi.org/10.1111/j.1529-8027.2010.00290.xTest